TYK2 is reported to be overexpressed in the prostate (Ide et al., 2008; Santos et al., 2015), ovarian (Silver et al., 2004), cervical (Zhu et al., 2009), and breast (Song et al., 2008) cancers. The gene discussed is TYK2; the disease is cancer.